Clinical and dosimetric experience with MammoSite-based brachytherapy under the RTOG 0413 protocol

Journal of Applied Clinical Medical Physics

Volumn 8, Issue 4, 2007, Pages 176-184

  Wojcicka, Jadwiga B ^a   Lasher, Donette E ^a   Malcom, Ronald ^a   Fortier, Gregory ^a  

^a York Cancer Center   (United States)

Author keywords

Brachytherapy; Breast cancer; High dose rate; Irradiation; MammoSite; Partial breast

Indexed keywords

EID: 38049117850     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v8i4.2654     Document Type: Article

References (14)

1. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227-1232.
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347(16):1233-1241.
3. Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992;326(17):1097-1101.
4. Dolan JT, Fanchi TS, Miller CC 3rd, Brunicardi FC. Low use of breast-conservation surgery in medically indigent populations. Am J Surg. 1999; 178(6):470-474.
5. Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19(8):2254-2262.
6. Dickler A, Kirk MC, Chu J, Nguyen C. The MammoSite breast brachytherapy applicator: a review of the technique and outcomes. Brachytherapy. 2005;4(2):130-136.
7. Radiation Therapy Oncology Group (RTOG). NSABP Protocol B-39, RTOG Protocol 0413: a randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with Stage 0, I, or II breast cancer. Philadelphia (PA): RTOG; January 2005. [Available online at: www.rtog.org/members/protocols/0413/0413.pdf, cited November 21, 2005]
8. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55(2):289-293.
9. Edmundson GK, Vicini FA, Chen PY, Mitchell C, Martinez AA. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys. 2002:52(4):1132-1139.
10. Arthur D, Vicini F, Kuske R, et al. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy. 2002; 1(4):184-190.
11. The American Society of Breast Surgeons. Consensus statement for accelerated partial breast irradiation. Columbia (MD): The American Society of Breast Surgeons; April 30,2003. [Available online at: www.breastsurgeons.org/officialstmts/officialstmt3.shtml; cited September 18, 2007]
12. Kutcher GJ, Coia L, Gillin M, et al. Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys. 1994;21(4):581-638.
13. Vu KN, Dragun AE, Cole DJ, Jenrette JM. Accelerated partial breast irradiation using MammoSite brachytherapy: a multidisciplinary approach to breast-conservation therapy Commun Oncol. 2005;2(6):477-482.
14. Nath R, Anderson LL, Luxton G, Weaver KA, Williamson JF, Meigooni AS. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys. 1995;22(2):209-226.